Mydecine Innovations

Mydecine Innovations Group is a biotechnology company developing novel psychedelic-derived therapeutics and digital health solutions for mental health disorders, including PTSD, addiction, and depression.

We operate a world-class mycology and drug development program, creating next-generation psychedelic molecules designed for optimized therapeutic benefit.